A Treatment for Patients with METex14 Skipping Metastatic NSCLC ~ 10/4/22 @ 6pmSep 28, 20221 min readINTERESTED!? Please contact Sarah Sievering directly via text or call to 617-549-4146. Feel free to email her as well.ONS Boston Meeting 10.4.pdfDownload PDF • 1.20MB
NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress
NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!
Hello All! If interested in attending please contact Sarah directly at her email sarah.sievering@emdserono.com or by phone at 617-549-4146. Thank you!